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The effect of tunicamycin on synthesis and intracellular transport of pig small intestinal aminopeptidase 
N (EC 3.4.11.2), sucrase-isomaltase (EC 3.2.1.48 - 10) and maltase-glucoamylase (EC 3.2.1.20) was 
studied by labelling of mucosal explants with [“S]methionine. The expression of the microvillar enzymes 
was greatly reduced by tunicamycin but could be partially restored by leupeptin, suggesting the existence 
of a mechanism whereby newly synthesized, malprocessed enzymes are recognized and degraded. In the 
presence of tunicamycin, polypeptides likely to represent non-glycosylated forms of the enzymes persisted 
in the Mg’+-precipitated membrane fraction, indicating that high mannose glycosylation is essential for 
transport to the microvillar membrane. Treatment of aminopeptidase N and sucrase-isomaltase with endo 
F reduced the size of the high mannose forms approximately to those seen in the presence of tunicamycin. 
The complex forms were also sensitive to endo F but did not coincide with the high mannose forms after 
treatment, indicating that the size difference cannot alone be ascribed to processing of N-linked 
carbohydrate. 
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1. INTRODUCTION 
Tunicamycin is an antibiotic that inhibits N- 
linked high mannose glycosylation of proteins [ 11. 
The drug does not directly interfere with in- 
tracellular transport of newly synthesized proteins 
and is therefore suitable for studying the impor- 
tance of N-linked glycosylation for the transport to 
the cell surface [2,3]. From the results obtained so 
far for several secretory and membrane proteins it 
seems that this type of processing is of variable im- 
portance. One explanation for this could be that 
glycosylation is necessary to a varying extent for 
the newly synthesized polypeptides to acquire and 
maintain a stable conformation [2,3]. 
During synthesis, the microvillar enzymes, in- 
cluding aminopeptidase N (EC 3.4.11.2), sucrase- 
isomaltase (EC 3.2.1.48-10) and maltase-gluco- 
amylase (EC 3.2.1.20) receive N-linked high man- 
nose glycosylation [4-61. However, it is not certain 
to what extent glycosylation determines the route 
of transport through the cell. By studying the ef- 
fect of swainsonine on transport, it was concluded 
that interference with the trimming and complex 
glycosylation does not seriously affect the trans- 
port to the microvillar membrane [7]. 
Here, the importance of N-linked glycosylation 
for the transport of microvillar enzymes was 
studied in organ-cultured explants of intestinal 
mucosa by using tunicamycin. In addition, endo F, 
a glycosidase that cleaves both high mannose and 
complex N-linked oligosaccharides from glycopro- 
teins [a], was used to characterize the differently 
glycosylated forms of the microvillar enzymes. 
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2. EXPERIMENTAL 
2.1. Materials 
Chemicals and equipment for performing organ 
culture of intestinal explants were obtained as in 
[9]. Tunicamycin was a product of Sigma (St. 
Louis, MO) and leupeptin was purchased from 
Bachem Feinchemikalien AG (Bubendorf). Endo- 
P-N-acetylglucosaminidase F (endo F) from Flavo- 
bacterium meningosepticum (manufacturer: NEN 
Chemicals GmbH, Dreieich) was kindly given by 
Dr P. Bjerrum, Department of Biophysics, Panum 
Institute, Copenhagen. 
Pig small intestines were kindly given by the 
Department of Experimental Pathology, Rigs- 
hospitalet , Copenhagen. 
2.2. Labelling of explants in organ culture 
Organ culture of pig small intestinal explants 
[lo] was performed as in [9]. In experiments with 
tunicamycin and leupeptin, the inhibitors were pre- 
sent in the medium at 20 fig/ml and 2 rg/ml, 
respectively. After culture, the explants were 
frozen at - 80°C until further processing. 
2.3. Treatment with endo F 
Immunoprecipitated aminopeptidase N and 
sucrase-isomaltase were resuspended in 100 ~1 of 
100 mM sodium phosphate (pH 6. l), containing 50 
mM EDTA, 1% 2-mercaptoethanol, 1% Triton 
X-100 and 0.1% sodium dodecyl sulphate and 
denatured by boiling for 2 min prior to the addi- 
tion of 2.5 ~1 (1.7 units) of endo F. The samples 
were incubated at 37°C for 20 h. Similarly, pre- 
treated control samples without the addition of 
glycosidase were incubated in parallel. 
2.4. Other methods 
Fractionation of the labelled explants into a 
Mg’+-precipitated membrane fraction, a 
microvillar fraction and a soluble fraction and im- 
munopurification of the enzymes were carried out 
as in [4,11]. Sodium dodecyl sulphate-polyacryl- 
amide gel electrophoresis was (SDS-PAGE) per- 
formed as in [12] and fluorography of the gels as 
in [13]. 
3. RESULTS AND DISCUSSION 
In the presence of tunicamycin, a polypeptide of 
M, 115 000 of aminopeptidase N, not seen in the 
control explants, could be detected (fig.1). This is 
of similar size to the primary translation product 
of the enzyme and thus represents a non- 
glycosylated form of aminopeptidase N [14]. 
However, tunicamycin severely reduced the expres- 
sion of aminopeptidase N (and other microvillar 
enzymes), both during a 20-min pulse (fig.1) and 
during continuous labelling for 20 h (not shown). 
Leupeptin, a proteinase inhibitor of bacterial 
origin [15], partially restored the expression of the 
microvillar enzymes, enabling the detection of the 
labelled enzymes in the various subcellular frac- 
tions and thus making it possible to study the im- 
portance of N-linked glycosylation for in- 
tracellular transport. Fig.2 shows the labelling of 
aminopeptidase N, sucrase-isomaltase and 
maltase-glucoamylase from the Mg2+-precipitated 
membrane fraction and microvillar fraction of 
controls and tunicamycin-exposed explants. For all 
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Fig. 1. Explants, preincubated for 3 h in the absence (- ) 
or presence (+ ) of tunicamycin were labelled for 20 min 
by adding [‘%]methionine (220 &i/ml) to the culture 
medium. Aminopeptidase N was immunopurified from 
Triton X-IOO-solubilized extracts of the explants [4] and 
subjected to SDS-PAGE. After electrophoresis, the gel 
was prepared for fluorography. Exposure time: 5 days 
(l), 30 days (2). Apparent A4, values (x 10W3) are shown. 
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Fig.2. Explants, preincubated for 2 h in the presence of 
leupeptin and in the absence ( - ) or presence (+ ) of 
tunicamycin, were labelled for 2 h by adding 
[35S]methionine (100 &i/ml) to the culture medium. 
Aminopeptidase N (l), sucrase-isomaltase (2) and 
maltase-glucoamylase (3) were immunopurified from the 
Mg’+-precipitated membrane fraction (MS”) and the 
microvillar fraction (Mic) and subjected to SDS-PAGE. 
After electrophoresis, the gels were prepared for 
fluorography. Exposure time: 3-l days. Apparent M, 
values (x 10m3) are shown. 
3 enzymes, the control pattern was principally 
similar; the Mg’+-precipitated membrane fraction 
contained a lower A4, polypeptide, bearing high 
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mannose glycosylation and a polypeptide of higher 
M,, representing the mature, complex glycosylated 
enzyme [4,5]. Only the latter form was present in 
the microvillar fraction and the soluble fraction 
did not contain detectable amounts of any of the 
enzymes (not shown). In the tunicamycin-exposed 
explants, additional molecular forms of all 3 en- 
zymes were visible in the Mg*+-precipitated mem- 
brane fraction. For aminopeptidase N, the 
polypeptide of A4, 115 000 was seen. For sucrase- 
isomaltase and maltase-glucoamylase, molecular 
forms smaller than the high mannose glycosylated 
forms, were seen, corresponding to polypeptides 
of A4,225 000 and 200 000, respectively. In analogy 
with aminopeptidase N, it seems reasonable to pro- 
pose that these polypeptides represent newly syn- 
thesized, non-glycosylated forms of the two en- 
zymes. This interpretation is supported by the ex- 
periment shown in fig.3, where treatment with en- 
do F reduced the size of the high mannose 
glycosylated forms of aminopeptidase N and 
sucrase-isomaltase approximately to that of the 
lower A4, polypeptides, seen in the presence of 
tunicamycin. Interestingly, the MI225 000 form of 
sucrase-isomaltase appeared as a doublet. It is 
noteworthy that authors in [16], using cell-free 
translation, obtained two polypeptides of rabbit 
sucrase-isomaltase of lower A4, than the mature 
single chain precursor, probably representing non- 
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Fig.3. Aminopeptidase N (1) and sucrase-isomaltase (2) 
were immunopurified from Triton X-lOO-solubilized 
extracts of explants [4], labelled for 2 h with 
[35S]methionine (100 ,.Ki/ml). The purified enzymes 
were incubated in the presence (+ ) or absence ( - ) of 
endo F as described in section 2 and subjected to 
SDS-PAGE. After electrophoresis, the gel was prepared 
for fluorography. Exposure time: 4 days. Apparent M, 
values (x 10e3) are shown. 
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glycosylated forms of the enzyme. Though the 
doublet seen here most likely reflects a partial 
cleavage of the hydrophobic anchor, the possibility 
also exists that it could represent different but 
closely related gene products. 
The additional molecular forms, seen in the 
presence of tunicamycin, were not detectable in the 
microvillar or soluble fractions. Even at the high 
concentration of tunicamycin used, the predomi- 
nant molecular forms of all 3 enzymes were the 
high mannose and complex glycosylated polypep- 
tides. This confirms our earlier observation of the 
inability of tunicamycin to inhibit completely the 
N-linked glycosylation in the explants [14]. We 
have no explanation for this phenomenon, but it 
shows that the normally processed, newly syn- 
thesized enzymes are also normally transported to 
the microvillar membrane. This demonstrates that 
tunicamycin does not itself directly interfere with 
the intracellular transport. 
Our results indicate that N-linked glycosylation 
is essential for the transport of newly synthesized 
enzymes to the microvillar membrane. The ability 
of leupeptin to partially restore the expression of 
the enzymes uggests that these are rapidly degrad- 
ed unless they become high mannose glycosylated 
during, or shortly after translation; an observation 
also made for fibronectin and the acetylcholine 
receptor [3]. The presence of the non-glycosylated 
forms of the enzymes in the Mg2+-precipitated 
membrane fraction rather than in soluble form in- 
dicates that membrane insertion of the nascent 
polypeptides takes place even in the absence of 
glycosylation and that degradation is at least in- 
itiated when the polypeptide resides in the mem- 
brane. A crinophagic pathway leading to the 
lysosomal compartment has been proposed to exist 
in the enterocyte [171, but degradation occurring in 
the rough endoplasmic reticulum or the Golgi com- 
plex would also be compatible with recently pro- 
posed models for catabolic regulation of protein 
expression [ 181. 
The failure of the non-glycosylated enzymes to 
reach the microvillar membrane might lead to the 
suggestion that N-linked oligosaccharides act as 
‘sorting signals’, directing the enzymes to their cor- 
rect destination [3]. However, for several mem- 
brane and secretory proteins it has been shown that 
expression of non-glycosylated forms can take 
place at the cell surface [3]. Another role for this 
type of processing would be to ensure that other- 
wise unstable polypeptides become protected from 
rapid degradation and therefore survive a first step 
of ‘quality control’ in the intracellular transport 
towards their final destination. 
The property of endo F to cleave both high man- 
nose and complex types of N-linked glycosylation 
[8] makes it useful to examine whether the con- 
siderable increase in M, (about 25000) from the 
high mannose to the complex glycosylated form of 
the enzymes might possibly be attributed to 
another type of processing. For both aminopep- 
tidase N and sucrase-isomaltase, both the high 
mannose and the complex glycosylated forms were 
susceptible to the action of endo F, as expected. 
However, the fact that the high mannose and com- 
plex glycosylated polypeptides for both enzymes 
exhibited separate bands after endo F treatment, 
indicates that the h4, difference between these two 
forms cannot be ascribed solely to structural dif- 
ferences in N-linked carbohydrate; if this had been 
the case, one should have expected the two bands 
to coincide after the treatment with endo F& We 
have previously proposed that O-linked glycosyla- 
tion also takes place during intracellular transport 
of the enzymes [7]. Our present results support our 
earlier observation. 
ACKNOWLEDGEMENTS 
Dr H. Sjostrom and Dr 0. Nor&r are thanked 
for valuable discussion of the manuscript. G.M.C. 
was supported by a grant from NATO. The work 
was supported by a grant from the Danish Medical 
Research Council (project 12-3505). 
REFERENCES 
[II 
PI 
[31 
[41 
PI 
@I 
Schwarz, R.T. and Datema, R. (1980) Trends 
Biochem. Sci. 5, 65-67. 
Gibson, R., Kornfeld, S. and Schlesinger, S.(1980) 
Trends Biochem. Sci. 5, 290-293. 
Olden, K., Parent, J.B. and White, S.L. (1982) 
Biochim. Biophys. Acta 650, 209-232. 
Danielsen, E.M. (1982) Biochem. J. 204, 639-645. 
Danielsen, E.M., Sjiistriim, H. and Noren, 0. 
(1983) Biochem. J. 210, 389-393. 
Ahnen, D.J., Mircheff, A.K., Santiago, N.A., 
Yoshioka, C. and Gray, G.M. (1983) J. Biol. 
Chem. 258, 5960-5966. 
31 
Volume 166, number 1 FEBS LETTERS January 1984 
[7] Danielsen, E.M., Cowell, G.M., Noren, O., 
Sjostrom, H. and Dorling, P.R. (1983) Biochem. J. 
216, in press. 
[8] Elder, J.H. and Alexander, S. (1982) Proc. Natl. 
Acad. Sci. USA 79, 4540-4544. 
[9] Danielsen, E.M., Sjostrom, H., Nor&r, O., Bro, B. 
and Dabelsteen, E. (1982) Biochem. J. 202, 
647-654. 
[lo] Browning, T.H. and Trier, J.S. (1969) J. Clin. 
Invest. 48, 1423-1432. 
[ll] Danielsen, E.M. and Cowell, G.M. (1983) J. 
Biochem. Biophys. Methods 8, 41-47. 
[12] Laemmli, U.K. (1970) Nature 227, 680-685. 
[13] Bonner, W.M. and Laskey, R.A. (1974) Eur. J. 
Biochem. 46, 83-88. 
[14] Danielsen, E.M., Noren, 0. and Sjostrom, H. 
(1983) Biochem. J. 212, 161-165. 
[15] Umezawa, H. (1976) Methods Enzymol. 45, 
678-695. 
[16] Wacker, H., Jaussi, R., Sonderegger, P., Dokow, 
M., Ghersa, P., Hauri, H.-P., Christen, P. and 
Semenza, G. (1981) FEBS Lett. 136, 329-332. 
[17] Blok, J., Ginsel, L.A., Mulder-Stapel, A.A., 
Onderwater, J.J.M. and Daems, W.T. (1981) Cell 
Tissue Res. 215, 1-12. 
[18] Bienkowski, R.S. (1983) Biochem. J. 214, l-10. 
32 
